These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1232992

  • 1. Chemical analytic approaches to the definition of uremic toxins.
    Furst P, Bergstrom J, Gordon A, Zimmermann L.
    Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
    Lamperi S, Buoncristiani U, Carozzi S, Cozzari M, Icardi A, Trasforini D.
    Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
    [Abstract] [Full Text] [Related]

  • 4. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [Abstract] [Full Text] [Related]

  • 7. Methodology for identification of serum middle molecules.
    Buzio C, Montagna G, Calderini C, Manari A, Migone L.
    Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J, Klahr S, Bricker NS.
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [Abstract] [Full Text] [Related]

  • 9. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)].
    Cueille G.
    J Chromatogr; 1978 Jul 01; 146(1):55-65. PubMed ID: 670358
    [Abstract] [Full Text] [Related]

  • 10. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P, Zimmerman L, Bergström J.
    Clin Nephrol; 1976 Apr 01; 3(2):178-88. PubMed ID: 1277595
    [Abstract] [Full Text] [Related]

  • 11. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
    Asaba H, Alvestrand A, Bergström J, Fürst P, Yahiel V.
    Clin Nephrol; 1982 Feb 01; 17(2):90-5. PubMed ID: 7067171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Studies on the significance of middle molecular retention products as uremia toxins].
    Goubeaud G, Leber HW, Schott HH.
    Verh Dtsch Ges Inn Med; 1982 Feb 01; 83():1244-6. PubMed ID: 611827
    [No Abstract] [Full Text] [Related]

  • 14. Middle molecular weight substances and uremic polyneuropathy.
    Dukanović L, Petrović J, Potić J.
    Acta Med Iugosl; 1990 Feb 01; 44(2):117-28. PubMed ID: 2162129
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of uremic middle molecules in regular hemodialysis patients.
    Asaba H, Alvestrand A, Fürst P, Bergström J.
    Clin Nephrol; 1983 Apr 01; 19(4):179-87. PubMed ID: 6851254
    [Abstract] [Full Text] [Related]

  • 16. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May 01; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV, Yushko LA, Sakhno LA, Nikolaev VG, Nikolaev AV, Grinenko DV, Mikhalovsky SV.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 May 01; 35(3):287-308. PubMed ID: 17573628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981 May 01; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.